Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart failure drug showdown: which works better?

NCT ID NCT07199088

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 24 times

Summary

This study tests whether adding acetazolamide or metolazone to standard diuretic therapy helps people with acute decompensated heart failure get rid of excess fluid faster and leave the hospital sooner. About 320 adults with severe fluid overload will be randomly assigned to one of the two drugs. The goal is to see which option is safer and more effective at reducing hospital stays and preventing kidney problems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE, DIASTOLIC are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Quaid e Azam Medical College , bahawalpur

    RECRUITING

    Chak Four Hundred Fifty-four, Punjab Province, Pakistan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.